2018 annual financial data
Sutro Biopharma 2018 Operating margin
Direct answer
Operating margin was -96.89%.
Operating income was -37.22M USD and net income was -35.32M USD.
Operating cash flow was 12.68M USD.
Get free Sutro Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 38.42M USD
- Operating income
- -37.22M USD
- Net income
- -35.32M USD
- Operating cash flow
- 12.68M USD